Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Teligent, Inc. to Present at the Raymond James 39th Annual Institutional Investors Conference on Wednesday March 7, 2018


Posted on: 05 Mar 18

BUENA, N.J., March 05, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at the Raymond James 39th Annual Institutional Investors Conference. The Conference is taking place March 4-7, 2018 at the J.W. Marriott Grande Lakes, Orlando, FL.

Jason Grenfell-Gardner, President and CEO and Damian Finio, Chief Financial Officer of Teligent, Inc. will present on Wednesday March 7th at 9:15 a.m. ET. 

The presentation will be webcast and will be accessible online on the investors section of the Company's website at http://www.teligent.com.  A replay will be available for 30 days.  

About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company.  Our mission is to be a leading player in the specialty generic prescription drug market.  Learn more on our website www.teligent.com.

Contact:
Martin Wilson
Teligent, Inc.
856-336-9120
www.teligent.com

GlobeNewswire
globenewswire.com

Last updated on: 06/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.